[ET Net News Agency, 10 May 2024] JW THERAP-B (02126) rose 23% to HK$2.3, breaking
above the 100-D SMA of HK$2.015.
It hits an intra-day high of HK$2.3, hitting an 1-month high, and an intra-day low of
HK$1.8. The total shares traded was 6.87 million, with a value of HK$14.17m. The active
buy/sell ratio is 93:7, with net buying turnover of HK$11.68m. CITIGROUP GLOBAL accounts
for greatest net responsive buying turnover of HK$204,327, with volume weighted average
price of HK$2.047. CHINA INT'L CAPITAL CORP HK accounts for greatest net responsive
selling turnover of HK$2.17m, with volume weighted average price of HK$2.116. The stock
has risen a combined 25% over the past 2 consecutive trading days.

Basic Information
=================

---------------------------------
Nominal 2.300 % Chg +22.99%
High 2.300 Low 1.800
Shares Tr 6.87m Turnover 14.17m
10-D SMA 1.891 %H.V 40.222
20-D SMA 1.814 VWAP 2.064
50-D SMA 1.906 RSI14 76.056
---------------------------------
Status: Breaking above the 100-D SMA, hitting an 1-month high, active buy/sell ratio is
93:7, with net buying turnover of HK$11.68m, rising a combined 25% over the past 2
consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
JW THERAP-B (02126) 2.30 +22.99
GENSCRIPT BIO (01548) 12.50 -0.64
INNOVENT BIO (01801) 41.45 +2.22
JXR (01951) 3.03 -1.30
EVEREST MED-B (01952) 25.90 +3.19
WUXI BIO (02269) 14.64 +0.41
WUXI APPTEC (02359) 38.05 +2.01
BEIGENE (06160) 99.80 -0.15
ZAI LAB (09688) 16.02 +0.75
AKESO (09926) 50.00 -0.99
---------------------------------------------
(ed)